Received: 19 June 2021
DOI: 10.1002/bkcs.12385
Revised: 30 July 2021
Accepted: 6 August 2021
C O M M U N I C A T I O N
Singlet oxygen-responsive photorelease of tyramine
Dong Yeun Jeong1,2 | Seung Yeon Yi1 | Youngmin You1,2
1Division of Chemical Engineering and Materials
Science, Ewha Womans University, Seoul,
Republic of Korea
2Graduate Program in System Health Science
and Engineering, Ewha Womans University,
Seoul, Republic of Korea
Abstract
A system capable of photoreleasing tyramine has been developed. The
photodonor system consists of an isoindole cage of tyramine and a bis-
cyclometalated Ir(III) complex singlet oxygen (1O2) photosensitizer. Photo-
irradiation at a wavelength of 365 nm produces tyramine, as evidenced by
mass spectrometry and 1H NMR spectroscopy. The photorelease proceeds
through two steps involving the formation of a Diels–Alder-type [2 + 4] cyclo-
Correspondence
Youngmin You, Division of Chemical
Engineering and Materials Science, Ewha
Womans University, Seoul 03760,
Republic of Korea.
1
adduct of O2, followed by the slow and spontaneous decomposition of the
adduct into tyramine and 2-benzoylbenzophenon.
K E Y W O R D S
Funding information
Midcareer Research Program, Grant/Award
Number: NRF-2019R1A2C2003969
iridium complex, photocage, photodelivery, singlet oxygen, tyramine
Tyramine, 2-(4-hydroxyphenyl)ethylamine, belongs to the
family of biogenic trace amines in the human body.
Although the trace level of tyramine remains lower than
those of classical biogenic amino neurotransmitters, such
as γ-aminobutyric acid, local concentrations at neural syn-
apses are considerably high.1 Growing evidence indicates
that tyramine is intimately involved in a variety of neuro-
physiological processes. For examples, Borowsky and co-
workers found that neurotransmission is mediated by
tyramine binding of G protein-coupled receptors.2 The
disruption in the homeostasis of tyramine elicits fatal neu-
rodegenerative conditions. Psychiatric disorders, such as
depression, hypertension, and schizophrenia, are linked
to the failure of optimal level of tyramine.3 The other
pathological conditions, including migraine and Parkin-
sonism, are also proposed to be related with the
dysregulation of tyramine.4,5 However, despite the patho-
physiological importance, the molecular mechanism
underlying the biological actions of tyramine has yet been
fully established. The immaturity is due to the underdevel-
opment of molecular tools of tyramine. In particular,
stimuli-responsive molecular donors of tyramine remain
sparse in the literature, although they are anticipated to
be employed for therapeutic purposes.
Thus, it is anticipated that photodonors of tyramine will
serve as powerful tools to study the biological actions of
tyramine. Despite the prospects, there is only one report of
a photodonor of tyramine. Etchenique and co-workers
found that a Ru(II) diimine complex could liberate a tyra-
mine monodentate ligand under photoillumination at a
wavelength of 450 nm.6
In this research, we developed a photodonor of tyra-
mine (DPSY4). DPSY4 was based on 1,3-diphenyl-2H-
isoindole (Scheme 1). Tyramine was incorporated into the
isoindole core through the nitrogen atom. DPSY4 is highly
reactive toward the Diels–Alder-type [2 + 4] cycloaddi-
tion reaction with singlet dioxygen (1O2, hereafter). The
1O2-adduct, an endoperoxide, is spontaneously cleaved
into tyramine and 2-benzoylbenzophenone (BBP, hereaf-
1
ter). We employed a O2 photosensitizer to trigger the
two-step release of tyramine. We previously validated the
1O2-mediated photouncaging of hydrogen sulfide7 and
β-phenethylamines.8 This strategy is valuable as the pho-
toexcitation wavelength can be conveniently controlled
by choosing a 1O2 photosensitizer.9 Herein, we report the
synthesis and reactivities of DPSY4. The photorelease
reaction was characterized with mass spectrometry and
1H NMR and UV–vis absorption spectroscopy.
One viable approach to attaining high-precision release
is to employ photons. The photoinduced release can be
executed noninvasively with very high spatiotemporal pre-
cisions. In addition, the progress of photoinduced release
can be controlled by a photon dose-dependent manner.
DPSY4 was prepared through consecutive reductive
amination reactions between BBP and tyramine in the
presence of NaBH4 in a 13% yield (Scheme 2). DPSY4
exhibited insufficient stabilities under light and an aer-
obic condition. This limited stability prohibited long-
Bull Korean Chem Soc. 2021;1–4.
© 2021 Korean Chemical Society, Seoul & Wiley-VCH GmbH
1